(Food-Beverage-News.Com, September 11, 2019 ) The global bovine serum albumin market is estimated to be valued at USD 255 million in 2019 and is projected to reach USD 304 million by 2025, recording a CAGR of 3.0%. Due to the growing livestock population and the subsequent increase in demand for blood-derived products, the market for bovine serum albumin is growing.
By form, the global bovine serum albumin market is segmented into dry and liquid forms. The demand for the dry form of BSA is high due to benefits offered, such as long shelf-life, stability, ease of handling, and transportation. In most instances, the end-users prefer using the dry form since it is easier to dilute as well.
Based on end user, the bovine serum albumin market is segmented into life sciences industry, food industry, feed industry, and research institutes. The demand for BSA stems majorly from the life sciences industry since it is an excellent carrier of drugs. It is also used in different cell culture applications. The demand for vaccines comes from North America due to various health issues, which the people in the region face. This growing demand for vaccination would widen the application of BSA in drug delivery.
The technical-& diagnostic-grade of BSA is the most extensively used grade due to its characteristic features such as solubility properties and ease of filtration. Its cost-effective nature has also made it a preferred option as a protein standard in the diagnostic industry. Some of the commonly used grades of BSA are the standard grade, protease-free, low endotoxin grade, protease- and DNase-free grade, biotinylated BSA grade, and microbiological grade. The low endotoxin grade of BSA is specifically manufactured to meet the requirements of bacterial and mammalian cell culture applications.
Major players such as Thermo Fisher Scientific (US), Bio-Rad Laboratories, Inc (US), Merck KGAA (Germany), Itoham Yonekyu Holdings Inc (Japan), Proliant Biologicals (US), Kraeber & Co Gmbh (Germany), Rockland Immunochemicals Inc (US), Rocky mountain biologicals (US), BelHealth investment partners, LLC (US), Bio-Techne Corporation (US), Prospec-Tany Technogene Ltd (Israel), and LGC Group (UK), (Singapore) in the bovine serum albumin market are focusing on new product launches, expansions & investments, and mergers & acquisitions, to expand their global footprint.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.